Good Documentation Practice and Record Keeping Regulations (FDA & EMA)

Why Should You Attend:

Good documentation Practices (GDP) is an essential factor that needs to be closely followed by the personnel in any regulated environment as a process for a successful project completion including observations of unanticipated responses that are required to be accurately recorded and verified.

This 60-min Webinar covers the essentials of GDP, its definition, purpose, and importance. Then expands on general rules and principles of GDP (US & EU), General tips for Laboratory Notebook documentation and finally discussing GDP enforcement by regulatory bodies in different countries with some examples of FDA citations.

If you are involved in any product manufacturing, knowing GDP regulations is a must for you. It prevents a lot of errors and minimizes the chance of being spotted by the regulatory bodies in their audits.

Areas Covered in the Webinar:

The outline of this training includes:

• Definition, Purpose, and Importance
• General Rules and Principles of GDP
• Requirements of Records
• General Tips in GDP:
• Signature / initial and the meaning
• Copying records
• Document maintenance
• Recording the time and date
• Correction of errors
• Rounding rules
• Back dating
• Missing data
• Voiding / cancelling records
• Recreating / rewriting records
• Deviations
• Rules Governing Medicinal Products in the European Union (Vol. 4: Documentation)
• What is new in the Latest Version?
• GDP Enforcement (examples from FDA warning letters)

Frequently Asked Questions:

1. Can you explain why blue pen is not acceptable?
2. Anything specific in document retention requirements in EU?
3. In the U.S., how long do documents have to be kept after the completion of a project/ clinical trial?
4. Related to 'what to do in case of errors': when mentioning the reason for error do you notate and include explanation it on the bottom?
5. Can paper documents be destroyed if electronic copies are kept of documentation?
6. What kind of original documents can’t be usually destroyed?

Who Will Benefit:

This webinar is applicable to the Medical Device and Pharmaceutical industries. Titles includes:

• Anybody who works in a regulated environment
• Manufacturing & Production Personnel / Managers
• Research and Development Personnel (R&D) / Managers
• Quality Assurance & Quality Control Personnel / Managers
• Laboratory Personnel / Managers
• Validation Specialists
• Clinical trial personnel
• Project Managers

Dr. Afsaneh Motamed Khorasani
Vice President of Medical Affairs, Easy Global Training

Dr. Afsaneh Motamed Khorasani, PhD, is a Medical and scientific Affairs expert and a Senior Scientist with a strong background in biomedical science and clinical trial/research. She has a tenured and diverse range of experience in medical affairs, basic and industrial clinical research and development, clinical trials, Medical and regulatory writing and intellectual property. She is currently the Vice President of Medical Affairs at Easy Global Training, which is a US-based firm providing global regulatory, quality and medical affairs training backed by consulting. Before joining this company, Dr. Motamed Khorasani has served as an independent consultant, director of medical affairs, senior medical sciences liaison, senior scientist and senior medical analyst at Merck (MDS), Johnson & Johnson, United States Pharmacopeia Convention (USP), Amgen, Baxter International, Covidien (eV3), Radient Pharmaceuticals, AMDL Diagnostics, Microbix Biosystems, Neometrix Consulting, Mount Sinai Hospital, Princess Margaret Hospital, and Vancouver General Hospital.

She has more than 20 years of experience and many National and international certificates in GLP, GMP, ICH-GCP and global regulatory compliance for clinical trials and is a member in a number of professional associations, including: American Association of Cancer Research (AACR), American Medical Writers Association (AMWA), Regulatory Affairs Professional Society (RAPS), American Society of Quality (ASQ), Project Management Institute (PMI), and Intellectual Property Institute of Canada (IPIC). Dr. Motamed Khorasani's research has focused on high throughput approaches in the context of cancer informatics with a particular interest in the use of comparative analysis for the mining of integrated oncology datasets that include protein-protein interaction and gene expression profiling. She has published and presented more than 50 papers, abstracts and articles in highly regarded scientific journals and high profile conferences and scientific meetings.

Follow us :